市场调查报告书
商品编码
1371964
到 2030 年生物催化现象和生物催化剂市场的预测:按类型、配方、应用和地区进行的全球分析Biocatalysis & Biocatalysts Market Forecasts to 2030 - Global Analysis By Type (Hydrolases, Transferases, Oxidoreductases, Lyases, Isomerases and Other Types), Formulation (Liquid, Gel and Powder), Application and By Geography. |
根据Stratistics MRC预测,2023年全球生物催化剂现象和生物催化剂市场规模将达到133.1亿美元,并在预测期内以8.5%的复合年增长率成长,到2030年达到235.6亿美元。
生物催化剂是指具有催化各种製程能力的生物(非人类)来源的化合物。生物催化剂是具有生物分解性、催化效率高、在良性环境中发挥作用等优点的有机材料。这些催化剂用于多种工业和商业性应用。生物催化剂广泛应用于生物製药、农业、纤维、生物燃料和其他生命科学领域。
根据美国农业部(USDA)统计,2018年,加拿大食品和饮料部门总销售额为870亿美元。
天然生物酵素越来越多地取代加工食品中的化学添加剂。此外,许多研究表明,加工食品中添加的生物防腐剂比危险化学物质更有利于消化健康。使用酵素等有机催化作用的生物催化在食品加工中具有许多优点。您可以提高生产力,改善风味和质地,并消除不必要的化学物质。食品製造商正在将生物催化剂作为一种永续且有效的解决方案,以满足因客户偏好不断变化和对便利性的渴望而推动的全球加工食品日益增长的需求。因此,市场成长的需求不断增加。
新型生物催化剂的开发和研究需要大量的资金。复杂的生物过程、高科技设备和科学技能都需要大量的财务支出。即使在研发完成后,长期的现场测试和法规认证也需要持续的支出。此外,由于该行业的高资本支出要求,小型企业和新兴企业无法进入市场。因此,这是市场拓展的主要障碍。
生物製药製造为生物催化剂和生物催化剂的应用提供了巨大的机会。由于单株抗体、酵素和重组蛋白等生物製药在治疗各种疾病方面的有效性和特异性,对它们的需求正在迅速增加。生物催化过程可以提高製造这些复杂分子的效率、产量和成本效益,有助于个人化医疗和标靶治疗的进步。生物催化剂和生物催化剂市场即将成长,并为各产业的发展提供了许多机会。
生物催化剂和生物催化剂市场正面临越来越多的环境影响问题。虽然生物催化剂透过实现高效和选择性的化学过程提供了一种环境友善的替代,但人们对其生产、基材采购和废弃物管理提出了担忧。环境永续性至关重要,要求工业公司采取永续实践,最大限度地减少资源消耗,并利用可再生资源开发生物催化剂。此外,重点是最佳化生物催化过程,以减少能源使用和废弃物产生。
COVID-19 疫情导致许多国家停工,导致市场终端用途产业出现一段时期的需求低迷时期。在三月中旬多出现购买狂潮之后,由于食品和其他必需品再次被囤积,对包装的需求有所下降。此外,新冠肺炎 (COVID-19) 大流行已经影响了包括食品和饮料行业在内的许多公司的业务。疫情对全球生物催化剂运作以及这些严重依赖生物催化剂的产业的影响,直接限制了生物催化剂和生物催化剂市场的扩张。
由于水解酶在酶水解中的重要作用,预计其份额最大。水解酶,包括蛋白酶、脂肪酶和淀粉酶,透过水解催化作用复杂的生物分子分解成更简单的化合物。这个过程在食品加工、製药、生物燃料和污水处理等多种应用中都至关重要。此外,水解酶的特异性、效率和环境效益推动了对水解酶的需求,为传统化学催化剂提供了绿色替代品。研究和开发的重点是提高酶稳定性、基材覆盖率和製程效率,以扩大应用范围并提高生物催化和生物催化剂市场的永续性。
由于快速成长和技术创新,食品和饮料领域预计在预测期内将出现良好成长。生物催化剂透过实现高效和永续的食品生产过程在该领域发挥着至关重要的作用。蛋白酶、淀粉酶和脂肪酶等酵素用于改善食品的风味、质地和营养成分。此外,它还可用于乳製品、烘焙、酿造、水果加工等生产,提高产品质量,同时减少能源消耗和废弃物。随着消费者健康意愿的增强以及对永续实践的日益关注,食品和饮料行业对生物催化剂的需求预计将激增,从而推动酶应用和生物加工技术的进步。
在估计期间,亚太地区占据最大的市场占有率。在该地区,人们对永续实践的认识不断提高以及对绿色化学解决方案的需求正在推动生物催化剂在製药、食品和饮料以及生物燃料等多种应用中的成长。在生物技术和製药产业崛起的推动下,中国、印度、日本和韩国等国家正成为该市场的主要参与者。此外,学术机构、研究机构和产业参与者之间的合作正在推动创新和技术进步,推动亚太生物催化剂和生物催化剂市场的发展,预计将大幅扩张并在全球占据主导地位。
由于北美地区的强劲成长和发展,预计在预测期内将出现获利成长。生物催化利用酵素等天然催化剂来加速化学反应,由于其永续的特性,在该地区获得了巨大的关注。在北美,以美国和加拿大为主要参与者,各行业对生物催化剂的需求正在迅速增长,包括製药、化学品、食品和饮料和饮料以及环境应用。此外,研发配合措施、与学术机构和企业相关人员的合作、生物技术和生物工程的金融投资等都有助于市场扩张。
According to Stratistics MRC, the Global Biocatalysis & Biocatalysts Market is accounted for $13.31 billion in 2023 and is expected to reach $23.56 billion by 2030 growing at a CAGR of 8.5% during the forecast period. The term "biocatalyst" refers to compounds with a biological (non-human) origin that have the ability to catalyse a variety of processes. They are organic, biodegradable, and have high catalytic efficiency, in addition to having the advantage of being able to function in mild settings. They are employed for several industrial and commercial applications. Widely used application areas of biocatalysts encompass biopharmaceuticals, agriculture, textile, biofuels, and other life science applications.
According to the United States Department of Agriculture (USDA), in 2018, Canada's total food and beverage industry sector sales reached $87 billion.
In processed foods, natural bioenzymes are increasingly replacing chemical-based additions. Additionally, a number of studies have shown that the biopreservatives added to processed foods are better for digestive health than dangerous chemicals. In the processing of food, biocatalysis, which uses organic catalysts like enzymes, has many benefits. It allows for increased productivity, greater flavour and texture modification, and the elimination of unwanted chemicals. Food manufacturers are turning to biocatalysts as sustainable and effective solutions in response to the rising global demand for processed foods, which is being driven by shifting customer preferences and the desire for convenience. Thus, there is an increasing demand for market growth.
New biocatalyst development and research require significant financial resources. Complex biological processes, high-tech equipment, and scientific skills all need significant financial outlays. Long-term field trials and regulatory certifications require ongoing spending even after research and development work is finished. Furthermore, small and medium-sized businesses and startups are prevented from entering the market due to the significant capital expenditure requirements of the industry. Therefore, it is a significant barrier to the market's expansion.
Biopharmaceutical manufacturing presents a significant opportunity for the application of biocatalysis and biocatalysts. The demand for biopharmaceuticals, including monoclonal antibodies, enzymes, and recombinant proteins, is rapidly increasing due to their effectiveness and specificity in treating various diseases. Biocatalytic processes can improve the efficiency, yield, and cost-effectiveness of manufacturing these complex molecules, contributing to the advancement of personalised medicine and targeted therapies. The biocatalysis and biocatalysts market is poised for growth and offers numerous opportunities for advancement in various industries.
The biocatalysis and biocatalysts market faces growing concern regarding its environmental impact. While biocatalysts offer eco-friendly alternatives by enabling efficient and selective chemical processes, concerns arise about their production, substrate sourcing, and waste management. Environmental sustainability is pivotal, urging industry players to adopt sustainable practices, minimise resource consumption, and develop biocatalysts from renewable sources. Furthermore, there's an emphasis on optimising biocatalytic processes to reduce energy usage and waste generation.
The COVID-19 epidemic has caused many countries to shut down, which has resulted in a period of low demand from the market's end-use industries. Food and other necessities are once again being stockpiled after widespread frenzied purchasing in several locations in mid-March, which is causing the demand for packaging to decline. Additionally, during lockdown, the COVID-19 pandemic is having an impact on the operations of numerous companies, including the food and beverage sector. The influence of the pandemic on the global operation of these industries, which heavily rely on biocatalysis and biocatalysts, is directly limiting the expansion of the biocatalysis and biocatalysts market.
The Hydrolases segment is estimated to hold the largest share, due to its vital role in enzymatic hydrolysis. Hydrolases, including proteases, lipases, and amylases, catalyse the breakdown of complex biomolecules into simpler compounds through hydrolysis. This process is crucial in various applications such as food processing, pharmaceuticals, biofuels, and wastewater treatment. Additionally, the demand for hydrolases is driven by their specificity, efficiency, and environmental benefits, offering a green alternative to traditional chemical catalysts. Research and development efforts are focusing on enhancing enzyme stability, substrate range, and process efficiency to expand the applications and improve sustainability in the biocatalysis and biocatalyst markets.
The Food & Beverages segment is anticipated to have lucrative growth during the forecast period, due to its rapid growth and innovation. Biocatalysts play a pivotal role in this sector by enabling efficient and sustainable food production processes. Enzymes such as proteases, amylases, and lipases are used to improve the flavours, textures, and nutritional profiles of food products. Moreover, they aid in the production of dairy, baking, brewing, and fruit processing, enhancing product quality while reducing energy consumption and waste. With a growing focus on health-conscious consumers and sustainable practices, the demand for biocatalysts in the food and beverage industry is expected to surge, driving advancements in enzymatic applications and bioprocessing techniques.
Asia Pacific commanded the largest market share during the extrapolated period. The region's increasing awareness of sustainable practices and the demand for green chemistry solutions drive the growth of biocatalysts in diverse applications such as pharmaceuticals, food and beverages, biofuels, and more. Countries like China, India, Japan, and South Korea are emerging as key players in this market, leveraging their thriving biotechnology and pharmaceutical industries. Additionally, collaborations between academic institutions, research organisations, and industry players are fostering innovation and technological advancements, propelling the Asia-Pacific Biocatalysis and Biocatalysts Market, which is expected to have significant expansion and dominance on a worldwide scale.
North America is expected to witness profitable growth over the projection period, due to its robust growth and evolution. Biocatalysis, employing natural catalysts like enzymes to drive chemical reactions, has gained significant traction in the region due to its environmentally friendly and sustainable attributes. North America, comprising the United States and Canada as major players, is witnessing a surge in demand for biocatalysts across various industries such as pharmaceuticals, chemicals, food and beverages, and environmental applications. Moreover, initiatives for research and development, partnerships between academic institutions and business stakeholders, and financial investments in biotechnology and bioengineering all contribute to the market's expansion.
Some of the key players in the Biocatalysis & Biocatalysts Market: E.I. Dupont De Nemours & Co., Codexis Inc., AB Enzymes Gmbh, Novozymes A/S, Dyadic International Inc., Royal DSM N.V., BASF SE, Arzeda Corporation, Chr. Hansen, The Soufflet Group, Amano Enzyme Inc., Debut Biotechnology, Inc., Zymtronix Catalytic Systems Inc., Unilever PLC, Soufflet Agro Rus, LLC, RP Management LLC, Piramal Enterprises Ltd., Codexis Inc., Lonza Group Ltd. and Afton Chemical.
In September 2023, Novozymes launches new biosolution to redefine the plant-based meat experience by enhancing texture and encouraging more consumers to choose plant-based alternatives. Novozymes is excited to offer Vertera® ProBite as a game-changing solution to the plant-based meat industry, opening up new possibilities to create today's and tomorrow's plant-based meat products with advanced texture and consumer-friendly labels.
In February 2023, AB Enzymes and Barentz sign exclusive distribution agreement extension. AB Enzymes and Barentz have announced the extension of the distribution agreement for bake & food enzymes in most of Europe with Barentz. The 5-year agreement further strengthens AB Enzymes' ambitions in the European markets.